中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
25期
28-30,35
,共4页
刘侠%张丽雅%李媛媛%吴东妮
劉俠%張麗雅%李媛媛%吳東妮
류협%장려아%리원원%오동니
左炔诺孕酮宫内缓释系统%子宫内膜异位症%卵巢功能
左炔諾孕酮宮內緩釋繫統%子宮內膜異位癥%卵巢功能
좌결낙잉동궁내완석계통%자궁내막이위증%란소공능
Levonorgestrel-releasing intrauterine system%Endometriosis%Ovarian function
目的:探讨左炔诺孕酮宫内缓释系统(LNG-IUS)在子宫内膜异位症术后患者中的应用效果。方法选取2010年1月~2012年1月因子宫内膜异位症在本院行腹腔镜保守性手术治疗的患者60例随机分为两组,A组30例采用LNG-IUS治疗,B组30例采用孕三烯酮治疗。随诊两年,比较术前及治疗后的血清CA125、E2水平、VAS和治疗后2年的两组复发率。结果两组治疗后的CA125水平与术前比较差异有统计学意义(P<0.01);两组治疗后2年的CA125水平比较差异有统计学意义(P<0.05)。 B组治疗后6个月、1年的血清E2水平与术前比较差异有统计学意义(P<0.05)。治疗后6个月,两组血清E2水平比较差异有统计学意义(P<0.05)。两组治疗后VAS与术前比较差异有统计学意义(P<0.01);治疗后1、2年,两组VAS比较差异有统计学意义(P<0.05)。治疗后2年,A组复发率明显低于B组,差异有统计学意义(P<0.05)。结论 LNG-IUS用于子宫内膜异位症术后辅助治疗,对卵巢功能影响较小,患者满意度高、依从性好、复发率低,阴道不规则流血是其主要副反应。
目的:探討左炔諾孕酮宮內緩釋繫統(LNG-IUS)在子宮內膜異位癥術後患者中的應用效果。方法選取2010年1月~2012年1月因子宮內膜異位癥在本院行腹腔鏡保守性手術治療的患者60例隨機分為兩組,A組30例採用LNG-IUS治療,B組30例採用孕三烯酮治療。隨診兩年,比較術前及治療後的血清CA125、E2水平、VAS和治療後2年的兩組複髮率。結果兩組治療後的CA125水平與術前比較差異有統計學意義(P<0.01);兩組治療後2年的CA125水平比較差異有統計學意義(P<0.05)。 B組治療後6箇月、1年的血清E2水平與術前比較差異有統計學意義(P<0.05)。治療後6箇月,兩組血清E2水平比較差異有統計學意義(P<0.05)。兩組治療後VAS與術前比較差異有統計學意義(P<0.01);治療後1、2年,兩組VAS比較差異有統計學意義(P<0.05)。治療後2年,A組複髮率明顯低于B組,差異有統計學意義(P<0.05)。結論 LNG-IUS用于子宮內膜異位癥術後輔助治療,對卵巢功能影響較小,患者滿意度高、依從性好、複髮率低,陰道不規則流血是其主要副反應。
목적:탐토좌결낙잉동궁내완석계통(LNG-IUS)재자궁내막이위증술후환자중적응용효과。방법선취2010년1월~2012년1월인자궁내막이위증재본원행복강경보수성수술치료적환자60례수궤분위량조,A조30례채용LNG-IUS치료,B조30례채용잉삼희동치료。수진량년,비교술전급치료후적혈청CA125、E2수평、VAS화치료후2년적량조복발솔。결과량조치료후적CA125수평여술전비교차이유통계학의의(P<0.01);량조치료후2년적CA125수평비교차이유통계학의의(P<0.05)。 B조치료후6개월、1년적혈청E2수평여술전비교차이유통계학의의(P<0.05)。치료후6개월,량조혈청E2수평비교차이유통계학의의(P<0.05)。량조치료후VAS여술전비교차이유통계학의의(P<0.01);치료후1、2년,량조VAS비교차이유통계학의의(P<0.05)。치료후2년,A조복발솔명현저우B조,차이유통계학의의(P<0.05)。결론 LNG-IUS용우자궁내막이위증술후보조치료,대란소공능영향교소,환자만의도고、의종성호、복발솔저,음도불규칙류혈시기주요부반응。
Objective To investigate application effect of levonorgestrel-releasing intrauterine system (LNG-IUS)in the treatment of endometriosis after conservasive laparoscopic surgery. Methods 60 patients with laparoscopic conservative operation therapy in our hospital from January 2010 to January 2012 were selected and randomly divided into 2 groups, LNG-IUS was used in group A(30 cases),gestrinone was used in group B(30 cases).Followed-up of two years,serum car-cinoembryonic antigen(CA125),serum estradiol(E2)level and VAS before surgery and after treatment was compared re-spectively.After treatment for 2 year,the recurrence rate of two groups was compared. Results After treatment,CA125 level in two groups was compared with before surgery respectively,there was statistical difference (P<0.01).After treat-ment of 2 years,CA125 level in two groups was compared,there was statistical difference (P<0.05).After treatment of 6-month and 1-year,E2 level in group B was compared with before surgery respectively,there was statistical difference(P<0.05).After treatment of 6-month,E2 level in two groups was compared,there was statistical difference (P<0.05).After treatment,VAS in two groups was compared with before surgery respectively,there was statistical difference (P<0.01).Af-ter treatment of 1-year and 2-year,VAS in two groups was compared respectively,there was statistical difference (P<0.05).After treatment of 2-year,the recurrence rate of group A was lower than that of group B,with statistical difference (P<0.05). Conclusion LNG-IUS applied in endometriosis adjuvant therapy has smaller impact on ovarian function,high patient satisfaction,better compliance and relapse rate.Irregular vaginal bleeding is its main side effect.